All News #Library
Biotech
Thymmune lands $37M from Biden`s ARPA-H for immune-rejuvenating therapies
29 Sep 2023 //
ENDPTS
Thymmune Secures $7M in Seed Financing to Develop Thymus Cell Therapy Platform
01 Mar 2023 //
BUSINESSWIRE

Market Place
Sourcing Support